A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors Meeting Abstract
| Authors: | Schram, A. M.; Drilon, A. E.; Macarulla, T.; O'Reilly, E. M.; Rodon, J.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C.; Lam, J. Y. C.; Varga, A.; De Langen, J.; Witteveen, P.; Boni, V.; Cerea, G.; Duruisseaux, M.; Liu, S. V.; Wasserman, E.; Tabernero, J. |
| Abstract Title: | A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309096 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS3654 |
| Notes: | Meeting Abstract: TPS3654 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
